2025 · 4th Quarter (Oct 1 - Dec 31)
Filed by W STRATEGIES, LLC.
Open official filingSource-reported fields
Literal source text
Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Implementation of the Inflation Reduction Act. Education around NIH funding Issues around drug pricing.
Literal federal measure citations: H.R.946
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
